← Back to Search

Other

Shockwave Therapy for Spinal Cord Injury

N/A
Recruiting
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No change in antispasmodic medications within the past three months or intended changes over the course of the trial
No change in antispasmodic medications within the past three months or intended changes over the course of the trial.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

This trial is investigating whether a non-invasive treatment, extracorporeal shockwave therapy (ESWT), is effective and safe for treating spasticity in people with spinal cord injury (SCI).

Who is the study for?
This trial is for adults over 18 with non-progressive traumatic spinal cord injury that happened more than a year ago, causing spasticity. They must have stable medication use for the past three months and not plan changes during the trial. Excluded are those with recent lower extremity surgery, ankle contracture, pregnancy, severe arthritis, thrombosis, cancer or recent injections for spasticity.Check my eligibility
What is being tested?
The study tests Extracorporeal Shockwave Therapy (ESWT) to treat spasticity in people with spinal cord injuries. It's a pilot randomized-controlled trial where half of the participants receive ESWT and half get sham treatment to compare effects on muscle stiffness and quality of life.See study design
What are the potential side effects?
ESWT is considered low-risk with no long-term side effects reported in similar conditions like post-stroke spasticity. However, potential short-term side effects may include mild pain or discomfort at the treatment site.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I haven't changed my muscle relaxer meds in the last 3 months.
Select...
I haven't changed my muscle relaxer meds in the last 3 months and don't plan to during the trial.
Select...
I have had a spinal cord injury for over a year without getting worse.
Select...
I can receive shockwave treatment and don't have recent infections or severe bleeding disorders.
Select...
I am 18 years old or older.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Change in Modified Ashworth Scale scores
Change in Modified Patient-Reported Impact of Spasticity Measure
Change in Modified Penn Spasticity Frequency Scale
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionExperimental Treatment1 Intervention
This group will receive a focused extracorporeal shockwave therapy treatment (three applications over three weeks), applied to the spastic medial gastrocnemius.
Group II: ControlPlacebo Group1 Intervention
This group will go through the same procedures as the intervention group, but the shockwave device will not touch their skin and thus they will receive no therapeutic effect.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Extracorporeal Shockwave Therapy
2008
Completed Phase 2
~110

Find a Location

Who is running the clinical trial?

Kessler FoundationLead Sponsor
173 Previous Clinical Trials
10,678 Total Patients Enrolled
3 Trials studying Spasticity
100 Patients Enrolled for Spasticity

Media Library

Extracorporeal Shockwave Therapy (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05432999 — N/A
Spasticity Research Study Groups: Intervention, Control
Spasticity Clinical Trial 2023: Extracorporeal Shockwave Therapy Highlights & Side Effects. Trial Name: NCT05432999 — N/A
Extracorporeal Shockwave Therapy (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05432999 — N/A
Spasticity Patient Testimony for trial: Trial Name: NCT05432999 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been enlisted to participate in this research?

"Affirmative. According to the clinicaltrials.gov database, this experiment is still recruiting participants with an original posting date of September 1st 2022 and latest update on September 13th 2022. The trial demands 30 patients between a single site."

Answered by AI

Are there any open slots for volunteers to participate in this experiment?

"Affirmative. According to clinicaltrials.gov, the trial is actively recruiting participants as of September 13th 2022 after initially posting on September 1st 2022. The study requires 30 patients from a single medical centre for completion."

Answered by AI

Who else is applying?

What state do they live in?
New Jersey
New York
What site did they apply to?
Kessler Foundation
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
2

Why did patients apply to this trial?

Trying all things to help increase my chances of healing quickly. Well I am 59 years old and my stiffness in my legs and the specificity has gotten to a point where is very hard for me to function in life and I will try anything to help myself to move forward and get my legs stronger it has been very tough for the past few years.
PatientReceived 2+ prior treatments
~6 spots leftby Oct 2024